Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Plasmodium vivax | cAMP-dependent protein kinase catalytic subunit, putative | 0.004 | 1 | 0.5 |
Echinococcus granulosus | cyclin B3 1 | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0035 | 0.6419 | 0.0934 |
Leishmania major | protein kinase A catalytic subunit isoform 1 | 0.004 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclin B3 1 | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | enhancer of mRNA decapping protein 4 | 0.004 | 0.9654 | 0.9125 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma brucei | cAMP-dependent protein kinase catalytic subunit 2 | 0.004 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclin b3 | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0035 | 0.6419 | 0.0934 |
Loa Loa (eye worm) | AGC/PKA protein kinase | 0.004 | 1 | 1 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclin B | 0.0035 | 0.6419 | 0.0934 |
Schistosoma mansoni | serine/threonine protein kinase | 0.004 | 1 | 1 |
Leishmania major | protein kinase A catalytic subunit | 0.004 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.004 | 1 | 1 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Entamoeba histolytica | cyclin family protein | 0.0035 | 0.6419 | 0.0934 |
Schistosoma mansoni | cyclin B | 0.0035 | 0.6419 | 0.0934 |
Leishmania major | protein kinase A catalytic subunit isoform 2 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Schistosoma mansoni | cyclin B3 | 0.0035 | 0.6419 | 0.0934 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Trichomonas vaginalis | AGC family protein kinase | 0.004 | 1 | 1 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Schistosoma mansoni | cyclins | 0.0035 | 0.6419 | 0.0934 |
Plasmodium falciparum | cAMP-dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Onchocerca volvulus | 0.0035 | 0.6419 | 0.5 | |
Entamoeba histolytica | cyclin, putative | 0.0035 | 0.6419 | 0.0934 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | enhancer of mRNA decapping protein 4 | 0.004 | 0.9654 | 0.9125 |
Toxoplasma gondii | AGC kinase | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 2 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 0.004 | 1 | 1 |
Entamoeba histolytica | cyclin, putative | 0.0035 | 0.6419 | 0.0934 |
Toxoplasma gondii | AGC kinase | 0.004 | 1 | 1 |
Giardia lamblia | Kinase, AGC PKA | 0.004 | 1 | 1 |
Loa Loa (eye worm) | AGC/PKA protein kinase | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma brucei | protein kinase A catalytic subunit, putative | 0.004 | 1 | 1 |
Trypanosoma brucei | cAMP-dependent protein kinase catalytic subunit 1 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Schistosoma mansoni | serine/threonine protein kinase | 0.004 | 1 | 1 |
Toxoplasma gondii | protein kinase, cAMP-dependent, catalytic chain | 0.004 | 1 | 1 |
Entamoeba histolytica | cyclin family protein | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 1 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclin B | 0.0035 | 0.6419 | 0.0934 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-8 M | ChEMBL. | 16002287 |
Inhibition (binding) | = 0 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-8 M | ChEMBL. | 16002287 |
Inhibition (binding) | = 6 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-6 M | ChEMBL. | 16002287 |
Inhibition (binding) | = 6 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-6 M | ChEMBL. | 16002287 |
Ki (binding) | 0 nM | Binding affinity against rat 5-HT7R expressed in HEK-293 cells; ND = not determined | ChEMBL. | 16002287 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.